Sage seeks $575M in public offering; Pfizer inks discovery pact with Chinese firm
→ Sage Therapeutics is hoping to raise a whopping $575 million through its latest public offering, announced a day after the biotech $SAGE received …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
